ifx-1
Showing 1 - 4 of 4
SSC Trial in Worldwide (IFX-1, IFX-1 + pembrolizumab combination therapy)
Recruiting
- SSC
- IFX-1
- IFX-1 + pembrolizumab combination therapy
-
La Jolla, California
- +24 more
Nov 10, 2022
Pyoderma Gangrenosum Trial (IFX-1, Placebo)
Not yet recruiting
- Pyoderma Gangrenosum
- IFX-1
- Placebo
- (no location specified)
Jul 28, 2023
Granulomatosis With Polyangiitis (GPA), Microscopic Polyangiitis (MPA) Trial in Worldwide (IFX-1, Placebo-IFX-1, Glucocorticoid
Completed
- Granulomatosis With Polyangiitis (GPA)
- Microscopic Polyangiitis (MPA)
- IFX-1
- +3 more
-
Leuven, Belgium
- +75 more
Aug 3, 2022
Hidradenitis Suppurativa (HS) Trial in Worldwide (IFX-1, Placebo)
Completed
- Hidradenitis Suppurativa (HS)
- IFX-1
- Placebo
-
Birmingham, Alabama
- +40 more
Mar 15, 2021